Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer

Icahn School of Medicine at Mount Sinai, New York

Northwell Health, Lake Success

Pennsylvania State University, University Park

Centre Georges François Leclerc, Dijon

Duke University Medical Center, Durham

CHRU de Brest Hôpital Morvan, Brest

Orlando Health Cancer Institute, Orlando

University of Miami, Miami

CHU de Bordeaux, Hôpital Haut-Lévêque, Pessac

Moffitt Cancer Center, Tampa

Institut régional du Cancer de Montpellier, Montpellier

University Hospitals of Cleveland, Cleveland

Henry Ford Hospital, Detroit

University of Iowa Hospitals and Clinics, Iowa City

Mayo Clinic Rochester, Rochester

University of Kansas Medical Center, Kansas City

Tenon Hospital, Paris

UT Southwestern Medical, Dallas

MD Anderson Cancer Center, Houston

Banner MD Anderson Cancer Center, Gilbert

Cedars-Sinai Medical Center, Los Angeles

Radiation Oncology and Gamma Knife Center of Oregon, Portland

University of Washington Medical Center (UWMC) - Radiation Oncology Center, Seattle

Cancer Care Northwest, Spokane Valley

Dartmouth-Hitchcock Medical Center, Lebanon

Hackensack Meridian Health, Hackensack

London Regional Cancer Center, London

Jewish General Hospital, Montreal

Institut Bergonié, Bordeaux

Addenbrookes Hospital, Cambridge

Atlantic Clinical Cancer Research Unit/QEII Health Sciences Centre, Halifax, Nova Scotia

Aberdeen Royal Infirmary, Aberdeen

GenesisCare, Oxford

Beatson West of Scotland Cancer Centre, Glasgow

Imperial College London, Saint Mary's Hospital, London